| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |